thinkstockJuly 7, 2015: Markets opened slightly higher on Tuesday but a reversal took just moments to set in and U.S. equities traded mostly lower for the remainder of the day. Commodities of…
How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more than just one drug candidate.
Investors looking to move down in volatility but stay fully invested may want to consider moving capital to any of these three value stocks.
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share of attention…
thinkstockMay 13, 2015: Markets opened higher on Wednesday but were able to eke out just modest gains by the end of the day. Both the dollar and crude oil weakened today while…
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
The five most shorted stocks trading on the New York Stock Exchange remained the same between the April 15 and April 30 settlement dates.
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
thinkstockMay 6, 2015: Markets opened higher on Wednesday but soon sank as growth expectations for the U.S. economy dimmed again. Fed Chairwoman Janet Yellen may have spooked investors by talking about high…
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.
